American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer

Brachytherapy

Volumn 11, Issue 1, 2012, Pages 68-75

  Beriwal, Sushil ^a   Demanes, D Jeffrey ^b   Erickson, Beth ^c   Jones, Ellen ^d   De Los Santos, Jennifer F ^e   Cormack, Robert A ^f   Yashar, Catheryn ^g   Rownd, Jason J ^c   Viswanathan, Akila N ^h  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e The University of Alabama at Birmingham   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

HDR; Interstitial; Vagina

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; BLADDER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CANCER SIZE; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTERSTITIAL RADIATION; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RECTUM; RECURRENT CANCER; SIGMOID; TREATMENT PLANNING; URETHRA; UTERINE CERVIX CANCER; VAGINA CANCER;

BRACHYTHERAPY; FEMALE; HUMANS; POSTOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, ADJUVANT; UNITED STATES; VAGINAL NEOPLASMS;

EID: 84855996941     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2011.06.008     Document Type: Article

References (75)

1. American Cancer Society: Available at: Accessed August 07, 2011. http://www.cancer.org/Cancer/VaginalCancer/DetailedGuide.
2. Aalders J.G., Abeler V., Kolstad P. Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patients. Gynecol Oncol 1984, 17:85-103.
3. McMeekin D.S., Benedet L.L., Broaddus R., et al. Gynecologic sites: Vagina. AJCC cancer staging manual 2010, 387-389. Springer, New York, NY. 7th ed. S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
4. Curran W., Whittington J.R., Peters A.J., et al. Vaginal recurrences of endometrial carcinoma: The prognostic value of staging by a primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys 1988, 15:803-808.
5. Dancuar F., Delcos L., Wharton J.T., et al. Primary squamous cell carcinoma of the vagina treated by radiotherapy: A failure analysis-The M.D. Anderson Hospital experience 1955-1982. Int J Radiat Oncol Biol Phys 1988, 14:745-749.
6. Viswanathan A.N., Erickson B.E., Rownd J. Image-based approaches tointerstitial brachytherapy. Gynecologic radiation therapy 2010, 247-259. Springer, Berlin, Heidelberg. A.N. Viswanathan, C. Kirisitis, B.E. Erickson (Eds.).
7. Perez C.A., Grigsby P.W., Garipagaoglu M., et al. Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 1999, 44:37-45.
8. Chyle V., Zagars G.K., Wheeler J.A., et al. Definite radiotherapy for carcinoma of the vagina: Outcome and prognostic factors. Int J Radiat Oncol Biol Phys 1996, 35:891-905.
9. Creutzberg C.L., van Putten W.L., Koper C., et al. Survival after relapse in patients with endometrial cancer: Results from a randomized trial. Gynecol Oncol 2003, 89:201-209.
10. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of cases of cancers of the endometrium, cervix, ovary, vulva and vagina. Semin Surg Oncol 1994, 10:31-46.
11. Urbanski K., Kojs Z., Reinfuss M., et al. Primary invasive vaginal carcinoma treated with radiotherapy: Analysis of prognostic factors. Gynecol Oncol 1996, 60:16-21.
12. Kucera H., Vavra N. Radiation management of primary carcinoma on the vagina: Clinical and histopathological variables associated with survival. Gynecol Oncol 1991, 40:12-16.
13. Hasbini C., Haie-Meder C., Morice P., et al. Outcome after salvage radiotherapy (brachytherapy+/- external) in patients with a vaginal recurrence from endometrial carcinomas. Radiother Oncol 2002, 65:23-28.
14. Wylie J., Irwin C., Pintilie M., et al. Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol 2000, 77:66-72.
15. Frank S.J., Jhingran A., Levenback C., et al. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 2005, 62:138-147.
16. Jereczek-Fossa B., Badzio A., Jassem J. Recurrent endometrial cancer after surgery alone: Results of salvage radiotherapy. Int J Radiat Oncol Biol Phys 2000, 48:405-413.
17. Kushner D.M., Fleming P.A., Kennedy A.W., et al. High dose rate (192)Ir afterloading brachytherapy for cancer of the vagina. Br J Radiol 2003, 76:719-725.
18. Kuten A., Grigsby P.W., Perez C.A., et al. Results of radiotherapy in recurrent endometrial carcinoma: A retrospective analysis of 51 patients. Int J Radiat Oncol Biol Phys 1989, 17:29-34.
19. Nori D., Hilaris B.S., Stanimir G., et al. Radiation therapy of primary vaginal carcinoma. Int J Radiat Oncol Biol Phys 1983, 9:1471-1475.
20. Leibel S.A., Wharam M.D. Vaginal and paraaortic lymph node metastases in carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 1980, 6:893-896.
21. Au S.P., Grigsby P.W. Statistical variation of late complication rates of the proximal vagina in the high-dose-rate and low-dose-rate brachytherapy treatment of cervical carcinoma. Int J Radiat Oncol Biol Phys 1999, 45:S420-S421.
22. Demanes D.J., Schutz K.L., Quackenbush J.J., et al. Low dose rate brachytherapy in vaginal carcinoma: Long-term outcome and morbidity. J Brachytherapy Int 2000, 16:11-24.
23. Jhingran A., Burke T.W., Eifel P.J. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 2003, 56:1366-1372.
24. Nag S., Yacoub S., Copeland L.J., et al. Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients. Int J Radiat Oncol Biol Phys 2002, 54:1153-1159.
25. Nag S., Martinez-Monge R., Copeland L.J., et al. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina. Gynecol Oncol 1997, 66:16-19.
26. Perez C.A., Camel H.M., Galakatos A., et al. Definitive irradiation in carcinoma of the vagina. Evaluation of long term results. Int J Radiat Oncol Biol Phys 1998, 15:1283-1290.
27. Stock R.G., Chen A.S.J., Seski J. A 30-year experience in the management of primary carcinoma of the vagina: Analysis of prognostic factors and treatment modalities. Gynecol Oncol 1995, 56:45-52.
28. Erickson B., Gillin M.T. Interstitial implantation of gynecologic malignancies. J Surg Oncol 1997, 66:285-295.
29. Pingley S., Shrivastara S.K., Sarin R., et al. Primary carcinoma of the vagina: Tata Memorial Hospital experience. Int J Radiat Oncol Biol Phys 2000, 46:101-108.
30. Erickson B., Albano K., Gillin M. CT-guided interstitial implantation of gynecologic malignancies. Int J Radiat Oncol Biol Phys 1996, 36:699-709.
31. Erickson B., Erickson S., Prost R., et al. Magnetic resonance imaging following interstitial implantation of pelvic malignancies. Radiat Oncol Investig 1995, 2:295-300.
32. Tanderup K., Nielsen S.K., Nyvang G.B., et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010, 94:173-180.
33. Viswanathan A.N., Dimopoulos J., Kirisits C., et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007, 68:491-498.
34. Beriwal S., Bhatnagar A., Heron D.E., et al. High-dose-rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy 2006, 5:218-222.
35. Bragg D.G., Hricak H. Imaging in gynecologic malignancies. Cancer 1993, 71:1648-1651.
36. Parikh J.H., Barton D.P., Ind T.E., et al. MR imaging features of vaginal malignancies. Radiographics 2008, 28:49-63.
37. Grigsby P.W. Role of PET in gynecologic malignancy. Curr Opin Oncol 2009, 21:420-424.
38. Lamoreaux W.T., Grigsby P.W., Dehdashti F., et al. FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys 2005, 62:733-737.
39. Yeh A.M., Marcus R.B., Amdur R.J., et al. Patterns of failure in carcinoma of the vagina treated with definitive radiotherapy alone: What is the appropriate field volume?. Int J Radiat Oncol Biol Phys 2000, 48:126-127.
40. McIntyre J.F., Eifel P.J., Levenback C., Oswald M.J. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer 1995, 75:836-843.
41. Miyamoto D.T., Tanaka C.K., Viswanathan A.N. Concurrent chemoradiation improves survival in patients with vaginal cancer. Int J Radiat Oncol Biol Phys 2010, 78:S120-S121. [Abstract].
42. Samant R., Lau B., E C., et al. Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum. Int J Radiat Oncol Biol Phys 2007, 69:746-750.
43. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004, 22:872-880.
44. Morris M., Eifel P.J., Jiandong L., et al. Pelvic radiation and concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999, 340:1127-1143.
45. Rose P.G., Bundy B.N., Watkiss J., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1133-1153.
46. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation an adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999, 340:1154-1161.
47. Gynecologic Oncology Group (GOG). GOG 238 a randomized trial of pelvic irradiation with or without concurrent weekly cisplatin in patients with pelvic-only recurrence of carcinoma of the uterine corpus. Available at: Accessed July 2, 2011. http://www.gog.org.
48. Blythe J.G., Hodel K.A., Wahl T.M., et al. Continuous postoperative epidural analgesia for gynecologic oncology patients. Gynecol Oncol 1990, 37:307-310.
49. Shaves M., Barnhill D.J., Bosscher J., et al. Indwelling epidural catheters for pain control in gynecologic cancer patients. Obstet Gynecol 1991, 77:642-644.
50. Popowski Y., Hiltbrand E., Joliat D., et al. Open magnetic resonance imaging using titanium-zirconium needles: Improved accuracy for interstitial brachytherapy implants?. Int J Radiat Oncol Biol Phys 2000, 47:759-765.
51. Choi J.C., Ingenito A.C., Nanda R.K., et al. Potential decreased morbidity of interstitial brachytherapy for gynecologic malignancies using laparoscopy: A pilot study. Gynecol Oncol 1999, 73:210-215.
52. Corn B.W., Lanciano R.M., Rosenblum N., et al. Improved treatment planning for the Syed-Neblett template using endorectal-coil magnetic resonance and intraoperative (laparotomy/laparoscopy) guidance: A new integrated technique for hysterectomized women with vaginal tumors. Gynecol Oncol 1995, 56:255-261.
53. Monk B.J., Walker J.L., Tewari K., et al. Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgery. Gynecol Oncol 1994, 52:222-228.
54. Stock R.G., Chan K., Terk M., et al. A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance. Int J Radiat Oncol Biol Phys 1997, 37:819-825.
55. Mock U., Kucera H., Fellner C., et al. High-dose-rate (HDR) brachytherapy with or without external-beam radiotherapy in the treatment of primary vaginal carcinoma: Long-term results and side effects. IntJ Radiat Oncol Biol Phys 2003, 56:950-957.
56. Viswanathan A.N., Cormack R., Holloway C.L. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys 2006, 66:91-99.
57. Georg P., Kirisits C., Goldner G., et al. Correlation of dose volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI based brachytherapy. Radiother Oncol 2009, 91:173-180.
58. Georg P., Lang S., Dimopoulos J.C., et al. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2011, 79:356-362.
59. Koom W.S., Sohn D.Y., Kim J.Y., et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 2007, 68:1446-1454.
60. Shah A.P., Strauss J.B., Gielda B.T., et al. Toxicity associated with bowel or bladder puncture during gynecologic interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2010, 77:171-179.
61. van't Riet A., Mak A.C., Moerland M.A., et al. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate. Int J Radiat Oncol Biol Phys 1997, 37:731-736.
62. Major T., Polgar C., Fodor J., et al. Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: A comparison between the Paris and dose-point optimized systems. Radiother Oncol 2002, 62:103-111.
63. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
64. ACR practice guideline for the performance of high-dose rate brachytherapy. Available at: Accessed July 02, 2011. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/ro/high_dose_rate_brachytherapy.aspx.
65. ACR practice guideline for the performance of low-dose rate brachytherapy. Available at: Accessed July 02, 2011. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/ro/low_dose_rate_brachytherapy.aspx.
66. ACR practice guideline for communication: radiation oncology. Available at: Accessed July 02, 2011. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/ro/comm_radiation_oncology.aspx.
67. Cormack R.A. Quality assurance issues for computed tomography, ultrasound and magnetic resonance imaging-guided brachytherapy. Int J Radiat Oncol Biol Phys 2008, 71:S136-S141.
68. Nath R., Anderson L.L., Meli J.A., et al. Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine. Med Phys 1997, 24:1557-1598.
69. Kubo H.D., Glasgow G.P., Pethel T.D., et al. High dose-rate brachytherapy treatment delivery: Report of the AAPM Radiation Therapy Committee Task Group No. 59. Med Phys 1998, 25:375-403.
70. Fine B.A., Piver M.S., McAuley M., et al. The curative potential of radiation therapy in the treatment of primary vaginal carcinoma. Am J Clin Oncol 1996, 19:39-44.
71. Nag S., Erickson B., Parikh S., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 2000, 48:779-790.
72. Orton C.G. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys 2001, 49:183-189.
73. Pai H.H., Souhami L., Clark B.G., et al. Isolated vaginal recurrences in endometrial carcinoma: Treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy. Gynecol Oncol 1997, 66:300-307.
74. Lieskovsky Y.E., Demanes D. Combination high-dose rate brachytherapy and external beam radiation therapy for the treatment of primary vaginal cancer: 5-year results. Int J Radiat Oncol Biol Phys 2004, 60:S308. [Abstract].
75. Au S.P., Grigsby P.W. The irradiation tolerance dose of the proximal vagina. Radiother Oncol 2003, 67:77-85.